E. Zhu, J. Oh, C. Dambkowski, and H. Shaheen, “APG777, a High-Affinity Humanized IgG1 Monoclonal Antibody Targeting IL-13, Demonstrates Prolonged Half-Life in Non-Human Primates”, J of Skin, vol. 8, no. 1, p. s315, Jan. 2024.